Skip Navigation


Rheumatology Advance Access originally published online on January 30, 2009
Rheumatology 2009 48(4):355-358; doi:10.1093/rheumatology/ken500
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/4/355    most recent
ken500v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chen, M.
Right arrow Articles by Zhao, M.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, M.
Right arrow Articles by Zhao, M.-H.
Related Collections
Right arrow Vasculitis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis

Min Chen1,*, Fang Wang1,* and Ming-Hui Zhao1

1Department of Medicine, Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.

Correspondence to: Min Chen, Department of Medicine, Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing 100034, China. E-mail: leimeng{at}public3.bta.net.cn


   Abstract

Objectives. Biomarkers for assessing disease activity of patients with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) are important in identifying relapse and guiding treatment. ANCA-induced neutrophil activation and degranulation played an important role in the pathogenesis of AAV and neutrophil gelatinase-associated lipocalin (NGAL) is a biomarker of neutrophil degranulation. The purpose of the current study is to investigate whether NGAL is a useful biomarker for assessing disease activity of patients with AAV.

Methods. Sequential sera from 19 patients with AAV at initial onset, remission and relapse were collected. Serum NGAL was detected using commercial ELISA kits. The association between serum NGAL and the Birmingham Vasculitis Activity Score (BVAS), ESR, CRP as well as serum ANCA was further investigated.

Results. The 19 patients had 19 relapses. The levels of serum NGAL in patients at initial onset and relapse were both significantly higher than that at remission (285.5 ± 65.5 ng/ml vs 96.7 ± 22.2 ng/ml, P < 0.05; 430.3 ± 98.7 ng/ml vs 96.7 ± 22.2 ng/ml, P < 0.05, respectively). It was still the case after adjusting for renal function. The levels of serum NGAL closely correlated with BVAS as well as the level of ESR, CRP and ANCA. Moreover, serum NGAL level had a closer correlation with BVAS than ESR, CRP and ANCA did.

Conclusion. Circulating NGAL could be used as a useful biomarker for assessing disease activity of patients with AAV.

KEY WORDS: Anti-neutrophil cytoplasmic autoantibody, Vasculitis, Neutrophil gelatinase-associated lipocalin


*Min Chen and Fang Wang contributed equally to this work.

Submitted 25 August 2008; revised version accepted 10 December 2008.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.